Related Experiment Videos
[Syndrome of papillary muscle dysfunction]
Revista Medica De Chile
|June 1, 1970
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.
Diabetic medicine : a journal of the British Diabetic Association·1999
Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo.
Experimental cell research·1999
Comparative study of the sorption of clomipramine and viloxazine hydrochlorides in Stedim 6 and PVC bags.
Bio-medical materials and engineering·1999
[Focal Neuropathies in SARS-CoV-2 Patients: Insights from a Single Center Experience].
Revista medica de Chile·2026
[Weight Recurrence After Bariatric Surgery: Definitions, Diagnosis, and Management Strategies. Part 2].
Revista medica de Chile·2026
[Perceptions of Communication Barriers Experienced by Migrants in Healthcare Services].
Revista medica de Chile·2026
[Hepatic Overlap Syndrome: Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. Case Review].
Revista medica de Chile·2026
Comparison of cognitive function, depression, fall-related behaviors, and quality of life in elderly individuals according to age.
Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026
Prognostic Factors for Postictal Agitation After Electroconvulsive Therapy in Older Adults With Depression.
Acta psychiatrica Scandinavica·2026
'The soul has no disability': inclusion of people with disabilities in rural South Africa.
Rural and remote health·2026
Handgrip strength in children, adolescents, and young adults with suspected myalgic encephalomyelitis/chronic fatigue syndrome.
Journal of translational medicine·2026
Changes in frailty, depression and loneliness among stroke survivors and their spouses.
Cerebrovascular diseases (Basel, Switzerland)·2026
A disease progression model comparing the long-term mobility and respiratory outcomes of adults with late-onset Pompe disease receiving cipaglucosidase alfa plus miglustat versus alglucosidase alfa.
Journal of comparative effectiveness research·2026